483 Oxygen Development Nov 2013

483 Oxygen Development Nov 2013

Tamara Henderson FDA$119.00 - Available Now

FDA investigators audited the Oxygen Development - Palm Springs, FL, United States facility and issued 3 inspectional observations (via FDA 483) on 22 Nov 2013.

Product details

  • Category: Foods & Cosmetics / Human Drugs
  • Number of Observations: 3
  • Inspection end: 22 Nov 2013
  • Location: Palm Springs, United States
  • FEI: 3009461317
Add To Cart